Here are a few highlights of cancer research news that have recently caught my attention:

• Nitin Patel, research scientist at the Institute for Genetic Medicine at the Keck School of Medicine of USC, comments in an article in the Huffington Post about the recent findings that revealed that GPR158, a protein based molecule, produces tendencies of increasing risks of ineffective hormonal therapies against prostate cancer. The research is reported in the online journal Public Library of Science ONE.
• A study conducted in Germany set out to find a correlation between patient information leaflets and their influence on persuading patients to get mammography screening. Results were published in Dtsch Arztebl Int.
• Chinese researchers have developed a breathalyzer device that could be used for lung cancer screening. Their work, described in a paper published in the journal Review of Scientific Instruments, demonstrates the potential of the device to be used as a breathalyzer for early lung cancer detection — possibly a safe and effective method of detecting cancer early that may save lives.
• Priscilla Slanetz, MD, MPH and two of her colleagues from Harvard Medical School wrote an opinion article in the New England Journal of Medicine about the federal Breast Density and Mammography Reporting Act and similar legislation in 21 states summarizing that these laws may increase unnecessary procedures and false positives for women at low- and moderate-risk of breast cancer.
• The 2015 AICR Cancer Risk Awareness Survey reveals a lack of understanding among Americans regarding cancer risk factors. See results.
• Exposure to sun poses risk of skin cancer even in the dark, a recent study by researchers at Yale revealed. In their experiment, scientists exposed mouse and human melanocyte cells to radiation from a UV lamp. Read more on their findings in Science.

Please feel free to contact Marisol Hernandez to share any comments.